Task: Answer the MCQ question.
Query: Which drug exhibits a 10.668% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any additional words.
Options:
a.) CCN1C(=O)C(CC(=O)Nc2ccccc2)N(Cc2ccccn2)C1=S
b.) CCn1nnnc1SCC(=O)N1c2ccccc2NC(=O)CC1C
Answer: a. CCN1C(=O)C(CC(=O)Nc2ccccc2)N(Cc2ccccn2)C1=S
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN1C(=O)C(CC(=O)Nc2ccccc2)N(Cc2ccccn2)C1=S
CCN1C(=O)C(CC(=O)Nc2ccccc2)N(Cc2ccccn2)C1=S
2-[1-ethyl-5-oxo-3-(pyridin-2-ylmethyl)-2-sulfanylideneimidazolidin-4-yl]-N-phenylacetamide